InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: None

Monday, 10/24/2011 9:43:52 AM

Monday, October 24, 2011 9:43:52 AM

Post# of 14
SHP rose from $8 to $30 since august! ShangPharma purchases Shanghai in-vivo drug research facility from Charles River (CRL) (SHP) 29.64 : Co announces it has, through its main Chinese subsidiary, Shanghai ChemPartner, acquired the assets in Charles River Laboratories' (CRL) Shanghai research facility. As part of the transaction, ShangPharma will take over Charles River's lease for the facility, which will provide the co with an additional 2,972 square meters.